DMT

Classic Psychedelic

DMT (N,N-dimethyltryptamine) is a fast-acting psychedelic tryptamine found in many plants and animals. Smoked, it produces an intense, immersive experience lasting only minutes; taken orally in the Amazonian brew ayahuasca (with an MAO inhibitor), its effects last several hours.

Also known as: N,N-DMT, Dimethyltryptamine, The spirit molecule, Dimitri, Changa (smoking blend), Ayahuasca (oral preparation)

Written by Psymerge Editorial Team · Last updated June 4, 2026

Key facts

CategoryClassic Psychedelic
OnsetSeconds (smoked/vaporised)
Peak1–3 minutes
Total duration5–20 minutes smoked; 4–6 hours as oral ayahuasca
After-effectsLargely back to baseline within 30–60 minutes after smoking

Overview

N,N-Dimethyltryptamine (DMT) is a naturally occurring psychedelic tryptamine found in numerous plants and, in trace amounts, in many animals including humans. Like other classic psychedelics, it acts mainly as an agonist at serotonin 5-HT2A receptors. What sets DMT apart is its speed: when smoked or vaporised, effects begin within seconds and resolve within roughly 15–20 minutes — sometimes called a 'breakthrough' experience for the intense, fully immersive visionary states it can produce (Strassman & Qualls, 1994).

DMT is not active when swallowed on its own, because the body's monoamine oxidase (MAO) enzymes break it down. Amazonian peoples solved this by combining DMT-containing plants with MAO-inhibiting vines to make ayahuasca, a brew used ceremonially for centuries that produces a much longer (4–6 hour) experience (Domínguez-Clavé et al., 2016).

This page summarises DMT's pharmacology, effects, and risks — including the important drug and dietary interactions that apply when an MAO inhibitor is involved — drawing on peer-reviewed literature and established harm-reduction resources.

History & origins

DMT was first synthesised in 1931 by the chemist Richard Manske, and its psychedelic effects in humans were documented in 1956 by the Hungarian chemist Stephen Szára. DMT-containing plants, however, had been used for far longer: Amazonian peoples have prepared the brew ayahuasca and DMT-rich snuffs (such as yopo) for centuries within ceremonial and healing traditions.

DMT was placed under international control in the 1971 Convention on Psychotropic Substances. Scientific interest revived in the 1990s when Rick Strassman conducted the first new human studies in decades at the University of New Mexico (Strassman & Qualls, 1994), and ayahuasca and DMT have since become a significant focus of modern psychedelic research.

Pharmacology & how it works

DMT is a classic serotonergic psychedelic that acts mainly as an agonist at 5-HT2A serotonin receptors, the same primary target as LSD and psilocin. It is structurally a tryptamine, closely related to serotonin itself, and is produced naturally in trace amounts in many organisms.

Chemical class
Tryptamine (classic serotonergic psychedelic)
Routes of administration
Smoked or vaporised (freebase), Oral, only when combined with an MAO inhibitor (ayahuasca), Insufflated, Intravenous (research settings)
Tolerance
Unlike many drugs, DMT shows little acute tolerance, and there is no evidence of physical dependence.

Pharmacokinetics

DMT is rapidly broken down by monoamine oxidase, which is why it is inactive when swallowed alone and extremely short-acting when smoked — onset within seconds, peak within minutes, and resolution within about 15–20 minutes. In ayahuasca, an MAO inhibitor blocks this breakdown so that orally taken DMT becomes active and lasts 4–6 hours.

Effects

Physical Effects

  • Rapid rise in heart rate and blood pressure
  • Pupil dilation
  • A sense of bodily vibration or pressure
  • Nausea, especially with oral ayahuasca, which often causes purging or vomiting
  • Dizziness or unsteadiness

Psychological Effects

  • Intense, fast-moving visual imagery and geometric patterns
  • A sense of entering another 'space' or reality (a 'breakthrough')
  • Perceived encounters with beings or entities
  • Ego dissolution and loss of the usual sense of self
  • Profound shifts in emotion, from awe to fear
  • Distorted perception of time

Spiritual Effects

  • Mystical or transcendent experiences
  • Feelings of unity, sacredness, or contact with something greater
  • A lasting sense of meaning or insight, particularly in ceremonial ayahuasca settings

Dosage Information

Low: 10–20 mg (vaporised freebase)
Medium: 20–40 mg (vaporised freebase)
High: 40–60+ (full 'breakthrough') mg (vaporised freebase)

Smoked freebase doses are listed here. Oral DMT is inactive without an MAO inhibitor; in ayahuasca, dose depends on brew strength and the MAOI used rather than a simple weight of DMT. Potency of plant material and extracts varies widely. Educational only and not an endorsement of use.

Risks & safety

Contraindications

DMT raises heart rate and blood pressure and can provoke intense, overwhelming psychological experiences, so it is generally inadvisable for:

  • Cardiovascular conditions: heart disease, uncontrolled high blood pressure, or a history of stroke.
  • Psychiatric history: a personal or family history of psychosis, schizophrenia, or bipolar disorder, which serotonergic psychedelics can destabilise.
  • Pregnancy and breastfeeding.

When DMT is taken as ayahuasca, the MAO-inhibiting component adds major additional contraindications (see interactions below).

Drug interactions

DMT itself interacts with other serotonergic drugs, but the most serious interactions arise from the MAO inhibitor used in ayahuasca.

  • SSRIs, SNRIs, MAOIs, and other serotonergic drugs: combining these with ayahuasca's MAOI can cause serotonin syndrome, a potentially life-threatening reaction.
  • Tyramine-rich foods and many medications: MAO inhibitors require dietary precautions and can interact dangerously with numerous prescription and over-the-counter drugs, stimulants, and certain supplements.
  • Stimulants: add cardiovascular strain.

This list is not exhaustive. Anyone considering ayahuasca should review MAOI interactions carefully and consult a clinician about all medications (Domínguez-Clavé et al., 2016).

Psychological distress & bad trips

Because smoked DMT comes on almost instantly and is extraordinarily intense, it can be deeply disorienting or frightening, especially without preparation or support. Difficult experiences may involve fear, panic, confusion, or a sense of losing control or 'dying'. With ayahuasca, challenging emotional material often surfaces over several hours. A safe setting and a sober, trusted sitter or facilitator substantially reduce the risk of harm.

Rare but serious risks

For most healthy people the acute physical risks of smoked DMT are modest, but they are not zero:

  • Cardiovascular strain: sharp rises in heart rate and blood pressure can be dangerous for people with heart conditions.
  • Accidents and injury: the rapid, incapacitating onset means an unprepared or standing user can fall or drop smoking equipment.
  • With ayahuasca specifically: serious harm and rare deaths have been linked mainly to MAOI drug or food interactions, pre-existing health conditions, dehydration, and adulterated or mixed brews — not to DMT alone.
  • Prolonged perceptual changes (HPPD) are uncommon but have been reported with psychedelics in general.

Vulnerable populations

Some groups face higher risk and should avoid DMT and ayahuasca:

  • People with a personal or family history of psychosis, schizophrenia, or bipolar disorder.
  • People with heart disease or uncontrolled high blood pressure.
  • People taking antidepressants or other serotonergic or MAOI-interacting medications (a particular danger with ayahuasca).
  • Adolescents, whose brains are still developing.
  • Pregnant or breastfeeding people.

Dependency & addiction potential

Like other classic psychedelics, DMT is not considered addictive. It does not produce physical dependence or compulsive drug-seeking, and it shows little acute tolerance. This does not make it safe for everyone — the psychological intensity and, with ayahuasca, the interaction risks remain significant.

Overdose

There is no established lethal dose for smoked DMT in healthy people, and the main acute dangers are psychological distress and cardiovascular strain rather than fatal toxicity. The picture is different for ayahuasca: although the brew itself is not usually lethal, serious and occasionally fatal outcomes have occurred — most often through interactions between its MAO inhibitor and incompatible medications or foods, pre-existing medical conditions, or adulterated brews. If someone experiences chest pain, a dangerously high heart rate, a very high temperature, agitation with muscle rigidity (possible serotonin syndrome), or loss of consciousness, seek emergency medical help immediately.

Harm Reduction

  • Smoke or vaporise DMT seated or lying down, never standing, as onset is almost immediate and incapacitating.
  • Always have a sober, trusted sitter present, and never use alone.
  • If considering ayahuasca, review MAOI drug and food interactions in detail, and stop interacting medications only under medical guidance — combining with SSRIs or other serotonergic drugs can be life-threatening.
  • Be honest with facilitators about your physical and mental-health history, and avoid unregulated retreats that screen participants poorly.
  • Prepare your set and setting: a calm, safe environment greatly reduces the chance of a frightening experience.
  • Start low and avoid redosing, especially when smoking, since effects escalate within seconds.
  • Avoid DMT entirely if you have a heart condition or a personal or family history of psychosis.

Cultural & spiritual context

DMT has a deep and genuine Indigenous history. For centuries, peoples across the Amazon basin have used the brew ayahuasca — which combines DMT-containing plants with MAO-inhibiting vines — and DMT-rich snuffs in ceremonial, healing, and divinatory contexts. This tradition continues today, and ayahuasca use has spread worldwide through syncretic churches and a growing 'ayahuasca tourism' industry. That global expansion raises real questions about cultural respect, safety in unregulated settings, and reciprocity with the Indigenous communities who hold this knowledge.

Laws vary widely by country and change frequently, so we don't track legal status here to avoid showing outdated information.

Check current worldwide legal status on Psychedelic Alpha

Frequently asked questions

How long does a DMT trip last?

Smoked or vaporised, DMT comes on within seconds, peaks within a few minutes, and is largely over within 15–20 minutes. Taken orally as ayahuasca (with an MAO inhibitor), the experience instead lasts about 4–6 hours.

Why isn't DMT active when swallowed on its own?

The body's monoamine oxidase (MAO) enzymes break DMT down before it can take effect. Amazonian ayahuasca works by adding an MAO-inhibiting plant, which blocks this breakdown so that oral DMT becomes active — but the MAOI also introduces serious drug and food interactions.

Is DMT addictive?

No. Like other classic psychedelics, DMT does not produce physical dependence or compulsive use, and it shows little acute tolerance. Its main risks are psychological intensity and, with ayahuasca, drug interactions — not addiction.

What is a DMT 'breakthrough'?

A 'breakthrough' is the fully immersive state that can occur at higher smoked doses, in which people often report entering an entirely different reality, encountering apparent beings, and losing their ordinary sense of self. It can be profound but also overwhelming.

Why is mixing ayahuasca with antidepressants dangerous?

Ayahuasca contains an MAO inhibitor. Combining an MAOI with SSRIs, SNRIs, or other serotonergic drugs can cause serotonin syndrome, a potentially life-threatening build-up of serotonin. Any decision to stop such medication should be made only with a clinician.

Need Integration Support?

Connect with qualified integration guides who can help you process and integrate your experiences safely and effectively.

Find a Guide

Related substances

References & further reading

  • Strassman, R. J., & Qualls, C. R. (1994). Dose-Response Study of N,N-Dimethyltryptamine in Humans: I. Neuroendocrine, Autonomic, and Cardiovascular Effects. Archives of General Psychiatry, 51(2), 85–97. https://doi.org/10.1001/archpsyc.1994.03950020009001
  • Domínguez-Clavé, E., Soler, J., Elices, M., et al. (2016). Ayahuasca: pharmacology, neuroscience and therapeutic potential. Brain Research Bulletin, 126, 89–101. https://doi.org/10.1016/j.brainresbull.2016.03.002
  • Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264–355. https://doi.org/10.1124/pr.115.011478
  • National Institute on Drug Abuse (NIDA). Psychedelic and Dissociative Drugs. https://nida.nih.gov/research-topics/psychedelic-dissociative-drugs
  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drug profiles. https://www.emcdda.europa.eu/publications/drug-profiles_en
  • Erowid. DMT Vault. https://www.erowid.org/chemicals/dmt/
  • DanceSafe. https://dancesafe.org/drug-information/
  • TripSit. Drug combinations chart. https://wiki.tripsit.me/wiki/Drug_combinations

About this article

Written by:
PE
Psymerge Editorial Team
Last updated June 4, 2026